Product Surveillance Registry

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

NCT Number	NCT01524276
Lead Sponsor	Medtronic
Conditions	Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders, Digestive Disorders, Intracranial Aneurysm, Mechanical Circulatory Support, Respiratory Therapy +8 more
Enrollment	100,000 participants
Start Date	2012-01
Primary Completion	2040-01 (estimated)
Study Completion	2040-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-17